Open-House-Biologika-Rabattverträge 2026-03a - Eculizumab (exkl. der Indikation gMG und NMOSD)
Original notice title
Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2026-03a - Eculizumab (exkl. der Indikation gMG und NMOSD)
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
20 / 100
Risk factors
The notice explicitly states this is not a public procurement subject to competition law; legal recourse is via social...
Structured data indicates EU-funded (isEuFunded: true), but XML notice explicitly says no-eu-funds. This may affect rep...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration until Aug 2027
- Supply of Eculizumab (excluding indications gMG and NMOSD) under discount agreements with participating health insurance funds.
- Agreement is open to all eligible pharmaceutical entrepreneurs; no exclusivity granted.
Show full summary
The tender is an Open House procedure for the conclusion of discount agreements (Rabattverträge) under § 130a Abs. 8 SGB V for the active substance Eculizumab (excluding the indications gMG and NMOSD). It is not a public procurement subject to competition law but a voluntary framework. All eligible pharmaceutical entrepreneurs can join at any time during the contract term (max 17 months from 1 April 2026 to 31 August 2027). No estimated value is provided. The procedure is open, with no negotiation on terms. Submission is via email or post, not through the e-procurement portal. The notice is in German, performance in Germany.
Risks
The notice explicitly states this is not a public procurement subject to competition law; legal recourse is via social...
Structured data indicates EU-funded (isEuFunded: true), but XML notice explicitly says no-eu-funds. This may affect rep...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical entrepreneur as defined in § 4 Abs. 18 AMG for the offered medicinal products.
- Must hold a valid marketing authorization for the medicinal product(s) or be otherwise entitled to place them on the market.
Administrative
- Must submit a self-declaration regarding authorization and reliability (Anlage 4).
Requirements may be incomplete.
Buyer
Location
Hamburg, DEU
Website
Identifier
992-80116-93
Activity
Health
Lots (1)
LOT-0001
Open-House-Biologika-Rabattverträge 2026-03a - Eculizumab (exkl. der Indikation gMG und NMOSD)
Conclusion of discount agreements for Eculizumab (excluding gMG and NMOSD) under an Open House procedure. All eligible pharmaceutical entrepreneurs can join at any time during the contract term.
Location
Duration
Category
Deadline
Award details
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Eculizumab (exkl. der Indikation gMG und NMOSD) im Rahmen eines Open-House-Verfahrens.
Value note
Show original TED data
Original TED description
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Eculizumab (exkl. der Indikation gMG und NMOSD) im Rahmen eines Open-House-Verfahrens.
Procurement Details
- Publication date
- 24 Feb 2026
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 132076-2026
Documents (1)
Similar tenders
Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)
Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
20 / 100
Risk factors
The notice explicitly states this is not a public procurement subject to competition law; legal recourse is via social...
Structured data indicates EU-funded (isEuFunded: true), but XML notice explicitly says no-eu-funds. This may affect rep...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications